Salzmann, Martin http://orcid.org/0000-0003-4310-4822
Hess, Klaus
Lang, Kristin
Enk, Alexander H.
Jordan, Berit
Hassel, Jessica C.
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 22 December 2021
Accepted: 13 April 2022
First Online: 11 May 2022
Conflict of interest
: M. Salzmann: honoraria and/or travel grants from Abbvie, Bristol-Myers Squibb (BMS), Merck, Merck Sharp & Dohme (MSD), Novartis, Pfizer, and Sanofi-Aventis. A.H. Enk: advisory honoraria from Biotest AG, MSD Oncology, Galderma, Janssen Cilag, and AbbVie as well as speaker’s honoraria from Roche Pharma. B. Jordan: honoraria for talks from Alexion, Temmler, Biomarin, Novartis; advisory board member of Alexion. J.C. Hassel: honoraria for talks from BMS, MSD, Roche, Novartis; advisory board member for MSD, Pierre Fabre; scientific grant support from BMS; travel grants from BMS, Pierre Fabre. K. Hess and K. Lang declare that they have no competing interests.